29 results match your criteria: "Gynecologic Oncology Clinic[Affiliation]"
Gynecol Oncol
August 2006
Department of Obstetrics and Gynecology-Gynecologic Oncology Clinic, R. Caraibas, 666 ap. 63-ZIP Code 05020-000, Vila Pompéia, São Paulo-SP, Brazil.
Objective: To compare the intraepithelial population of Langerhans' cells (LC) in normal cervix epithelium adjacent to cervical intraepithelial neoplasia grade 3 (CIN 3) and correlate to smoking habit.
Methods: Cases in this study included conization specimens from 48 women affected by CIN 3. The LC count was performed in areas without histopathologic alteration adjacent to CIN 3.
Eur J Gynaecol Oncol
March 2006
Gynecologic Oncology Clinic, Cukurova University Medical Faculty, Adana, Turkey.
In this study we investigated FHIT (Fragile Histidine Triad) protein alterations in cervical carcinomas to assess the relation of this gene with cervical cancer. Eighty-eight patients with surgically treated FIGO (International Federation of Gynecology and Obstetrics) stage IB carcinomas of the cervix were included in this study. Clinicopathologic prognostic factors were compared with FHIT expression status.
View Article and Find Full Text PDFEur J Gynaecol Oncol
February 2003
National Specialized Hospital for Active Treatment in Oncology, Gynecologic-Oncology Clinic, Sofia, Bulgaria.
Purpose Of Investigation: Our aim was to outline the treatment of carcinoma of the vulva at the National Oncological Centre in Sofia, Bulgaria.
Methods: We examined the records of 250 patients over a 10-year period treated at the Gynaecologic-Oncology Clinic of our Centre.
Results: There were 130 patients (52%) treated with surgery and radiation.